Navigation Links
Pharmaceutical Medical Affairs Functions Get a Boost in Budget, Staffing
Date:4/22/2011

CHAPEL HILL, N.C., April 22, 2011 /PRNewswire/ -- The growing importance of the medical affairs function coincides with a company's need to manage rapidly changing regulatory requirements in today's biopharmaceutical industry.

This year, nearly one-third of companies anticipate an increase in medical affairs funding of more than 10 percent. However, a top challenge still on the minds of medical affairs executives is insufficient resources, including budget and headcount, for developing and maintaining an effective medical affairs group.

"Medical Affairs Resources, Structures & Trends," primary research conducted by Best Practices, LLC's, provides medical affairs executives with recent trends in budget and staffing resources, key challenges and top success factors for the function.

Download a complimentary white paper at http://www3.best-in-class.com/rr1060.htm that includes selected best practices drawn from extensive primary research with executives from 25 leading biopharmaceutical companies.

The full 40-page report contains more than 100 benchmark metrics and 20 executive narratives, providing medical affairs executives with recent trends in budget and staffing resources, key challenges and top success factors for the function.

Key topics of this primary research include:

  • Organizational structures
  • Budget allocation for medical affairs functions and outsourcing
  • Recent and anticipated changes in resource levels
  • Impact on medical affairs functions on company success
  • Key success factors and challenges for medical affairs

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.  

BEST PRACTICES, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011
2. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
3. Jazz Pharmaceuticals Announces First Quarter 2011 Results Conference Call on May 3
4. Important Drug Product Notice: Luitpold Pharmaceuticals, Inc. Announces Temporary Suspension of Distribution and Manufacture of Drug Products
5. Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast
6. Savient Pharmaceuticals to Hold First Quarter 2011 Financial Results
7. Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield®
8. Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder
9. China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets
10. Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories
11. Merrimack Pharmaceuticals Announces that Recruitment is Open in a Phase 1 Combination Study of MM-111 with Multiple Treatment Regimens in HER2 Positive Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston ... and unparalleled access to global decision makers and innovative ... 800+ life science leaders during two impactful days. BioPharm ... provides delegates with additional networking opportunities with 4,500+ life ...
(Date:7/5/2017)... 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... received approval from the Israel Securities Authority to dual-list its ... common stock will commence trading on the TASE on July ... market capitalization of the Company, it is expected that Oramed ...
Breaking Medicine Technology:
(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance Group, a ... communities across North Carolina, is launching a charity event in conjunction with the ... the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy Network (BCAN) ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Donna Bergman, professor of ... and published an article in the medical science journal Physical Medicine and Rehabilitation ... article and the research that helped produce it, were written and conducted in ...
(Date:7/25/2017)... WI (PRWEB) , ... July 25, 2017 , ... ... Aloria Health, as medical director. Dr. Negrette has more than a decade of ... She has worked closely with individuals fighting addictions, eating disorders, psychotic and manic ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... Product Innovation in the prestigious CEO World Awards®. The coveted annual CEO World ... and services, CEO case studies, corporate social responsibility, and milestones from every major ...
(Date:7/24/2017)... PARK (PRWEB) , ... July 24, 2017 , ... Engineers ... is bio-compatible, because it produces the same kind of electrical energy that the body ... the form of moving electrons. This flow of electrons out of the battery is ...
Breaking Medicine News(10 mins):